Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma.

被引：0
|
作者：
Gounder, Mrinal M.
Rosen, Ezra
Parikh, Aparna Raj
Conley, Anthony Paul
Hong, David S.
Sheth, Siddharth
Mai, Nicholas
Sgroe, Erica
Mitchell, Ryan
Picard, Roxana
Brail, Les H.
Cote, Gregory Michael
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Erasca Inc, San Diego, CA USA
[6] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11522
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours
    Frappaz, Didier
    Federico, Sara M.
    Pearson, Andrew D. J.
    Gore, Lia
    Macy, Margaret E.
    DuBois, Steven G.
    Aerts, Isabelle
    Iannone, Robert
    Geschwindt, Ryan
    Van Schanke, Arne
    Wang, Rui
    Geoerger, Birgit
    EUROPEAN JOURNAL OF CANCER, 2016, 62 : 9 - 17
  • [42] AZURE: A Phase 1/2 Study of Blu-263 As Monotherapy and in Combination with Azacitidine in Patients with Advanced Systemic Mastocytosis
    DeAngelo, Daniel J.
    Reiter, Andreas
    George, Tracy, I
    Radia, Deepti H.
    Devlin, Marissa
    Dimitrijevic, Sasa
    Rinne, Mikael
    Scherber, Robyn
    Gotlib, Jason
    BLOOD, 2022, 140 : 6877 - 6878
  • [43] Trial in progress: Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors
    Kummar, Shivaani
    Barve, Minal
    Feldman, Eric
    Ma, Seunghyun
    Merchan, Jaime
    Im, Seock-Ah
    Rha, Sun Young
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [44] PHASE 1 STUDY OF AN ANTI-CD27 AGONIST AS MONOTHERAPY AND IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Shapira-Frommer, Ronnie
    van Dongen, Marloes G. J.
    Dobrenkov, Konstantin
    Chartash, Elliot
    Liu, Fang
    Li, Claire
    Wnek, Richard
    Patel, Manish
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A2 - A2
  • [45] Phase 1b/2 study of tivozanib in combination with durvalumab in subjects with advanced hepatocellular carcinoma (Deductive): Efficacy results in previously untreated patients
    Iyer, Renuka V.
    Li, Daneng
    Dayyani, Farshid
    Rowe, Julie Haewon
    Beg, Muhammad Shaalan
    Kasturi, Vijay
    Abrams, Thomas Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [46] A phase 1 dose-escalation study of safety, tolerability, and pharmacokinetics (PK) of ABBV-368 monotherapy and combination in patients (pts) with locally advanced or metastatic solid tumors
    Le Tourneau, Christophe
    Su, Wu-Chou
    Chung, Ki
    LoRusso, Patricia
    Lin, Chia-Chi
    Barlesi, Fabrice
    Shiah, Her-Shyong
    Angevin, Eric
    Spira, Alexander
    Patnaik, Amita
    Powderly, John
    Colevas, Dimitrios
    Chew, Helen
    Patel, Maulik
    Lambert, Stacie
    Li, Yan
    Da Costa, Daniel
    Blaney, Martha
    McDevitt, Michael
    Cassier, Philippe
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [47] A randomized phase II study of gemcitabine (GEM) plus S-1 combination chemotherapy versus GEM monotherapy in patients (pts) with advanced biliary tract cancer (BTC)
    Sasaki, T.
    Isayama, H.
    Ito, Y.
    Yasuda, I.
    Toda, N.
    Hanada, K.
    Matsubara, S.
    Maoguchi, H.
    Yashlma, Y.
    Kamada, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [48] Phase 1 Study of Cetuximab in Combination With 5-Fluorouracil, Cisplatin, and Radiotherapy in Patients With Locally Advanced Anal Canal Carcinoma
    Moreno, Victor
    Garcia-Carbonero, Rocio
    Maurel, Joan
    Feliu, Jaime
    CANCER, 2014, 120 (03) : 454 - 456
  • [49] Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
    Olivatto, Luis O.
    Vieira, Fernando M.
    Pereira, Bruno V.
    Victorino, Ana P.
    Bezerra, Marcos
    Araujo, Carlos M.
    Erlich, Felipe
    Faroni, Lilian
    Castro, Leonaldson
    Lusis, Edward C.
    Marins, Alessandra
    Ferreira, Carlos Gil
    CANCER, 2013, 119 (16) : 2973 - 2980
  • [50] Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study
    Yokota, K.
    Takenouchi, T.
    Fujimoto, M.
    Ihn, H.
    Uchi, H.
    Inozume, T.
    Kiyohara, Y.
    Uhara, H.
    Nakagawa, K.
    Furukawa, H.
    Wada, H.
    Noguchi, K.
    Shimamoto, T.
    Yamazaki, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S672 - S672
12345